BTL-754FF

BTL Industries, Inc.

Country / region:United States (US)Submission type:Traditional

Product code GEX· 21 CFR 878.4810

View Summary PDF

Company

United States (US)

Product code

GEX
21 CFR 878.4810

Predicate devices

7

Cited as predicate

0

Device details

FDA 510(k) registration fields

K number
K252561
Device name
BTL-754FF
Country / region
United States(US)
Product code
GEX
Device class
Class 2
Regulation number
21 CFR 878.4810
Date received
2025-08-13
Decision date
2026-02-18
Submission type
Traditional
Technology type
Er:YAG(AI inferred)
Clinical applications
Skin resurfacingPigment treatmentSurgical cutting
Primary application
Skin resurfacing
Classification source
AI classified

Indications for Use

The BTL-754-1 with 2940nm is intended for use in Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Laser skin resurfacing procedures for the treatment of:
- Acne scars
- Wrinkles

The BTL-754-1 with 1540nm is intended to be used for incision, excision, ablation, and coagulation (hemostasis) of soft tissue. The device is also indicated for the removal of pigmented lesions; photocoagulation of dermatological vascular lesions, including photothermolysis of blood vessels (treatment of facial and leg veins), for the treatment of periorbital and perioral wrinkles, for the treatment of back acne.

The BTL-754-1 with combined 1540nm and 2940nm is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing, treatment of wrinkles and textural irregularities.

BTL-754-4 handpiece has the following indications for use:
- The BTL-754-4 with 2940nm in Fractional mode is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia.
- The BTL-754-4 with 1540nm in Fractional mode is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars.
- The BTL-754-4 with combined 1540nm and 2940nm in Fractional mode is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions.
- The BTL-754-4 with 1540nm in Macro mode is intended for use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue.

Intended Use

The BTL-754FF device with BTL-754-1 handpiece has the following indications for use: The BTL-754-1 with 2940nm is intended for use in Coagulation, vaporization, ablation or cutting of soft tissue (skin) in Dermatology, Plastic Surgery, Gynecology, General Surgery, Podiatry and Ophthalmology (skin around the eyes). Laser skin resurfacing procedures for the treatment of: Acne scars, Wrinkles. The BTL-754-1 with 1540nm is intended to be used for incision, excision, ablation, and coagulation (hemostasis) of soft tissue. The device is also indicated for the removal of pigmented lesions; photocoagulation of dermatological vascular lesions, including photothermolysis of blood vessels (treatment of facial and leg veins), for the treatment of periorbital and perioral wrinkles, for the treatment of back acne. The BTL-754-1 with combined 1540nm and 2940nm is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing, treatment of wrinkles and textural irregularities. BTL-754-4 handpiece has the following indications for use: The BTL-754-4 with 2940nm in Fractional mode is intended for use in dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, pigmented lesions, and vascular dyschromia. The BTL-754-4 with 1540nm in Fractional mode is intended for use in coagulation of soft tissue, skin resurfacing procedures as well as treatment of melasma, striae, acne scars and surgical scars. The BTL-754-4 with combined 1540nm and 2940nm in Fractional mode is intended for dermatological procedures requiring coagulation, resurfacing, and ablation of soft tissue. Procedures include skin resurfacing and treatment of wrinkles, rhytides, furrows, fine lines, textural irregularities, dyschromia and pigmented lesions. The BTL-754-4 with 1540nm in Macro mode is intended for use in dermatological procedures requiring skin resurfacing and coagulation of soft tissue.

Device Description

The BTL-754FF device and the predicates are comprised of a system console and applicators.

Summary parsed at:2026-06-01 05:18:38 UTC

Predicate devices

7

K252561 references 7 predicate/reference devices

Cited as predicate

0

No later 510(k)s cite this device yet

Other submissions will appear here when they list K252561 as a predicate